Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.
暂无分享，去创建一个
Deepak L. Bhatt | E. Topol | S. Ellis | M. Roffi | D. Chew | M. Robbins | D. Mukherjee | J. Schneider
[1] C. Heeschen,et al. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. , 2000, Journal of the American College of Cardiology.
[2] P. Pasqualetti,et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. , 1999, Journal of the American College of Cardiology.
[3] A. Rebuzzi,et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. , 1999, Circulation.
[4] S. Steinhubl,et al. The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions. , 1998, Journal of the American College of Cardiology.
[5] F. Crea,et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. , 1998, The American journal of cardiology.
[6] B. Nowak,et al. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. , 1998, Circulation.